Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics Shares Outstanding 2010-2024 | NKTR

Nektar Therapeutics shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Nektar Therapeutics Annual Shares Outstanding
(Millions of Shares)
2023 190
2022 187
2021 183
2020 179
2019 175
2018 180
2017 156
2016 140
2015 132
2014 127
2013 116
2012 115
2011 113
2010 94
2009 93
Nektar Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 195
2023-12-31 190
2023-09-30 190
2023-06-30 190
2023-03-31 189
2022-12-31 187
2022-09-30 188
2022-06-30 187
2022-03-31 186
2021-12-31 183
2021-09-30 184
2021-06-30 183
2021-03-31 181
2020-12-31 179
2020-09-30 179
2020-06-30 178
2020-03-31 177
2019-12-31 175
2019-09-30 175
2019-06-30 175
2019-03-31 174
2018-12-31 180
2018-09-30 173
2018-06-30 182
2018-03-31 161
2017-12-31 156
2017-09-30 163
2017-06-30 155
2017-03-31 154
2016-12-31 140
2016-09-30 137
2016-06-30 136
2016-03-31 136
2015-12-31 132
2015-09-30 133
2015-06-30 132
2015-03-31 136
2014-12-31 127
2014-09-30 132
2014-06-30 127
2014-03-31 124
2013-12-31 116
2013-09-30 116
2013-06-30 116
2013-03-31 115
2012-12-31 115
2012-09-30 115
2012-06-30 115
2012-03-31 115
2011-12-31 113
2011-09-30 114
2011-06-30 114
2011-03-31 109
2010-12-31 94
2010-09-30 94
2010-06-30 94
2010-03-31 94
2009-12-31 93
2009-09-30 93
2009-06-30 93
2009-03-31 93
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.197B $0.090B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.648B 31.17
Chugai Pharmaceutical (CHGCY) Japan $57.871B 25.87
Takeda Pharmaceutical (TAK) Japan $41.080B 8.32
Merck (MKGAF) Germany $21.118B 20.48
Astellas Pharma (ALPMY) Japan $17.771B 28.06
Sandoz Group AG (SDZNY) Switzerland $15.585B 0.00
United Therapeutics (UTHR) United States $14.151B 15.09
Neurocrine Biosciences (NBIX) United States $13.594B 37.21
Shionogi (SGIOY) Japan $11.423B 9.93
Catalent (CTLT) United States $10.160B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.208B 0.00
Ionis Pharmaceuticals (IONS) United States $6.860B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.816B 7.49
Revolution Medicines (RVMD) United States $6.406B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.968B 0.00
Summit Therapeutics (SMMT) United States $5.623B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.538B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.337B 0.00
Corcept Therapeutics (CORT) United States $3.164B 28.67
Dyne Therapeutics (DYN) United States $2.963B 0.00
PTC Therapeutics (PTCT) United States $2.696B 0.00
Indivior (INDV) United States $2.245B 10.64
Recursion Pharmaceuticals (RXRX) United States $2.229B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.006B 11.40
Catalyst Pharmaceuticals (CPRX) United States $1.789B 17.41
NewAmsterdam Pharma (NAMS) Netherlands $1.770B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.615B 24.28
Ardelyx (ARDX) United States $1.401B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.374B 0.00
Pacira BioSciences (PCRX) United States $1.321B 12.56
Soleno Therapeutics (SLNO) United States $1.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.255B 0.00
Xencor (XNCR) United States $1.193B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.157B 0.00
4D Molecular Therapeutics (FDMT) United States $1.137B 0.00
Collegium Pharmaceutical (COLL) United States $1.031B 6.17
Ocular Therapeutix (OCUL) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.010B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.966B 15.05
Cassava Sciences (SAVA) United States $0.925B 0.00
Relay Therapeutics (RLAY) United States $0.895B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.893B 0.00
Cronos Group (CRON) Canada $0.867B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.795B 0.00
Harrow (HROW) United States $0.766B 0.00
ARS Pharmaceuticals (SPRY) United States $0.741B 0.00
Sage Therapeutics (SAGE) United States $0.656B 0.00
Exscientia (EXAI) United Kingdom $0.639B 0.00
Silence Therapeutics (SLN) United Kingdom $0.597B 0.00
Lexeo Therapeutics (LXEO) United States $0.556B 0.00
Altimmune (ALT) United States $0.525B 0.00
Savara (SVRA) United States $0.525B 0.00
Siga Technologies (SIGA) United States $0.524B 6.70
Lyell Immunopharma (LYEL) United States $0.520B 0.00
ProKidney (PROK) United States $0.511B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.474B 0.00
Heron Therapeutics (HRTX) United States $0.459B 0.00
Larimar Therapeutics (LRMR) United States $0.449B 0.00
OmniAb (OABI) United States $0.446B 0.00
Verve Therapeutics (VERV) United States $0.439B 0.00
Bioventus (BVS) United States $0.434B 16.61
Theravance Biopharma (TBPH) Cayman Islands $0.409B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.364B 0.00
Organogenesis (ORGO) United States $0.331B 62.50
Xeris Biopharma Holdings (XERS) United States $0.311B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.86
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Century Therapeutics (IPSC) United States $0.216B 0.00
ESSA Pharma (EPIX) Canada $0.215B 0.00
Incannex Healthcare (IXHL) Australia $0.214B 0.00
Eliem Therapeutics (ELYM) United States $0.213B 0.00
Aquestive Therapeutics (AQST) United States $0.210B 0.00
Prelude Therapeutics (PRLD) United States $0.208B 0.00
Fractyl Health (GUTS) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.198B 0.00
Elite Pharmaceuticals (ELTP) United States $0.195B 18.28
Zevra Therapeutics (ZVRA) United States $0.192B 0.00
Acrivon Therapeutics (ACRV) United States $0.187B 0.00
Pyxis Oncology (PYXS) United States $0.180B 0.00
Akebia Therapeutics (AKBA) United States $0.180B 0.00
Adherex Technologies (FENC) United States $0.169B 206.67
Context Therapeutics (CNTX) United States $0.164B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.148B 0.00
Cardiol Therapeutics (CRDL) Canada $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.140B 0.00
Metagenomi (MGX) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.139B 0.00
CytoDyn (CYDY) United States $0.137B 0.00
Karyopharm Therapeutics (KPTI) United States $0.136B 0.00
MediWound (MDWD) Israel $0.136B 0.00
Telomir Pharmaceuticals (TELO) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.126B 8.41
VAXART, INC (VXRT) United States $0.122B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
OptiNose (OPTN) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.114B 5.22
Journey Medical (DERM) United States $0.100B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Conduit Pharmaceuticals (CDT) United States $0.091B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
ProPhase Labs (PRPH) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.01
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Carisma Therapeutics (CARM) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
DURECT (DRRX) United States $0.044B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
SHINECO (SISI) China $0.024B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Talphera (TLPH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.05
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 29.19